New strategy for COVID-19 vaccination: targeting the receptor

Therapeutic Strategies in the Development of Anti-viral Drugs and

Articles in 2020 Cellular & Molecular Immunology

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development - ScienceDirect

PDF) Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

Emerging SARS-CoV-2 variants of concern and potential intervention

Understanding the Post COVID-19 Condition (Long COVID) in Adults

COVID-19 vaccine - Wikipedia

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Full article: Role of antibody-dependent enhancement (ADE) in the

Applications of genetic engineering in COVID-19 - ScienceDirect

Mucosal delivery of nanovaccine strategy against COVID-19 and its

A critical overview of current progress for COVID-19: development

The commonly available platforms and mechanisms for cancer vaccine

An overview of current drugs and prophylactic vaccines for